Client: Palliative Care Company.
A Palliative Care company was looking to gain a stronger understanding of the medical cannabis market in the US and learn how it would support their new device.
More specifically, the company was interested in gaining insights into preferred product specifications, physician pivot points for usage and recommendation to patients, and sales strategy.
Our Solution
- We developed a methodology that included two phases of primary research, physicians and patients, in all 21 of the states that have legalized medical cannabis.
- During the first phase, surveys were developed and administered to 105 medical oncologists and hematologist oncologists in the US.
- During the second phase, surveys were developed and administered to 150 cancer patients in the US.
Outcome
- A detailed presentation that provided an overview of the results of the study segmented by geography.
- GlobalData also included a summary of sentiments regarding the client’s device and provided recommendations for launch.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
